# Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression

> **NCT03047200** · PHASE1 · WITHDRAWN · sponsor: **Baylor Research Institute**

## Conditions studied

- Islet Cell Transplantation
- Type 1 Diabetes

## Interventions

- **BIOLOGICAL:** Islet cell transplantation

## Key facts

- **NCT ID:** NCT03047200
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-07
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** There were not patients that meet inclusion/exclusion criteria. Site decided to close study.
- **Last updated:** 2017-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03047200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03047200, "Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03047200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*